Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Earnings Call

Solesence Earnings Call: Key Takeaways

Solesence achieved record Q3 revenue and net income driven by lean management initiatives, though management lowered full-year EBITDA margin guidance due to first-half weakness.

Full earnings call on the Alfa Finder USA YouTube channel · Open on YouTube ↗
Highlights
Revenue GrowthQ3 revenue $20.2M, up 38% from $14.6M in Q3 2025.
Mgmt ConfidenceConfident in record revenue but cautious, lowering EBITDA margin guidance for 2026.
Demand VisibilityExpect at least $65M in shipped and on-hand orders by year-end.
Order BookOn-hand orders contribute to $65M year-end revenue target.
Margin TrendsGross margin 39.3%; OEE increased from 40% to 55% year-over-year.
Op. LeverageIndirect costs down seven-figure amount; expenses growing slower than top-line revenue.
Vol vs PriceGrowth driven by strategic brand partner expansion and favorable product mix.
Segment GrowthStrong growth in SPF-infused facial care, complexion products, and makeup.
New ClientsOver 60 brand partners and 300 SKUs currently in market.
Capex & DebtManufacturing footprint expanded from 80,000 to 300,000 square feet since 2022.
RegulatoryFDA approval of BMT UV filter creates new formulation opportunities for 2027.
CommentaryTransform and Transcend strategy focused on lean management and operational efficiency.
New LaunchesHybrid BMT products expected to reach consumers in 2027.

Growth

Q3 revenue grew 38% to $20.2M; gross margin expanded 1,550 bps to 39.3%.

Outlook

Guiding to $65M year-end revenue and 30% gross profit floor for 2026.

Risks

Management pivoted on EBITDA guidance, lowering it from double-digits to 'slightly below' without specific figures.

Source

The company's earnings call, NASDAQ: SLSN, and its 8-K filed with the SEC. Summary written with AI assistance from the call.

Read the 8-K ↗

Solesence, Inc.: key numbers

Share price
$1.60Close, Nov 16
Market cap
$113M
Shares outstanding
70.65MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Perfumes, Cosmetics & Other Toilet PreparationsSIC 2844

Today's reference numbers, updated daily. Not a valuation or a recommendation.

More from Solesence, Inc.

All →
4:57 PM ET 10-Q
Financial Results ▶ Call

Solesence Q3 2026 Results: Turns Profitable, Net Income $3.67M

Solésence, Inc. reported a net income of $3.67 million for the third quarter of 2026, a significant recovery from a $1.02 million net loss in the prior year period, driven by a 38% increase in total revenue. For the nine months ended September 30, 2026, the company generated $8.4 million in cash from operating activities, compared to a $10.4 million cash burn in the same period of 2025.

Key figure
Net income $3.67M
4:07 PM ET 8-K
Financial Results

Solesence Financial Results

Solésence reported record third quarter 2026 financial results, with revenue increasing 38% year-over-year to $20.2 million. The company achieved its highest-ever quarterly net income of $3.7 million, driven by operational excellence and strong demand from brand partners.

Term
Q3 2026

“We’re very pleased that Solésence delivered solid top line growth as well as steady operational and strategic progress in the third quarter, driven by key milestones across our Transform and Transcend framework. Most notably, we reached a major turning point by completing the primary investment and implementation phase of our first pillar, operational excellence. This elevated capacity and efficiency position us to meet robust demand from our brand partners today while seamlessly scaling for tomorrow. Paired with our continued innovation in novel formulations and expanding global presence, Solésence is uniquely positioned to deliver long-term, profitable growth and lead the market in meeting evolving consumer needs.”

Kevin Cureton, President and CEO

“By pairing record revenue and net income with strong margin expansion, we have positioned Solésence for sustained growth. The operational and financial improvements achieved throughout 2026 provide a strong foundation as we look ahead to 2027.”

Laura Riffner, Chief Financial Officer
4:55 PM ET 8-K
Loan & Debt

Solesence Debt Financing Update with Beachcorp, LLC

Solésence, Inc. entered into amendments for three separate loan agreements with affiliates of its controlling shareholder, Bradford T. Whitmore. The amendments extend the maturity dates for the Term Loan, A/R Loan, and Revolving Loan from April 30, 2027, to May 31, 2028.

Counterparty
Beachcorp, LLC
Term
through May 31, 2028
4:00 PM ET 8-K
Nasdaq/NYSE Compliance Notice

Solesence Nasdaq/NYSE Compliance Notice

Solésence, Inc. received a deficiency notice from Nasdaq on September 29, 2026, because its common stock closing bid price fell below the $1.00 minimum requirement for 30 consecutive trading days. The company has 180 calendar days, until March 29, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive trading days. If compliance is not met by then, the company may be eligible for an additional 180-day grace period if it meets other listing standards.

Counterparty
Nasdaq
Term
180 days

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.